IndiaTickerRekvina Laboratories Ltd - 526075 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Company dossier
Rekvina Laboratories
BSE:VINRKLB · ISIN INE092O01028
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Rekvina Laboratories
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Rekvina Laboratories Ltd - 526075 - Pre-Offer Advertisement & Corrigendum to Detailed Public StatementBSE · exchange filing · pdf
Source filing Rekvina Laboratories Ltd - 526075 - Announcement under Regulation 30 (LODR)-Open Offer - UpdatesBSE · exchange filing · pdf
Source filing Rekvina Laboratories Ltd - 526075 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Rekvina Laboratories Ltd - 526075 - Updates on Open OfferBSE · exchange filing · pdf
Source filing Rekvina Laboratories Ltd - 526075 - Announcement under Regulation 30 (LODR)-Open Offer - UpdatesBSE · exchange filing · pdf
Source filing Rekvina Laboratories Ltd - 526075 - Announcement under Regulation 30 (LODR)-Open Offer - UpdatesBSE · exchange filing · pdf
Source filing Rekvina Laboratories Ltd - 526075 - Letter of OfferBSE · exchange filing · pdf
Source filing Rekvina Laboratories Ltd - 526075 - Announcement under Regulation 30 (LODR)-Open Offer - UpdatesBSE · exchange filing · pdf
Source filing Rekvina Laboratories Ltd - 526075 - Financial Results For Quarter Ended & Year Ended On March 31, 2026.BSE · financial results · pdf
Source filing Rekvina Laboratories Ltd - 526075 - Board Meeting Outcome for Outcome Of Board Meeting Held On 21St May, 2026BSE · financial results · pdf
Source filing Rekvina Laboratories Ltd - 526075 - Board Meeting Intimation for Consider And Approve Financial Result For The QTR 4BSE · financial results · pdf
Source filing Rekvina Laboratories Ltd - 526075 - Shareholder Meeting / Postal Ballot-Outcome of EGMBSE · exchange filing · pdf
Source filing Rekvina Laboratories Ltd - 526075 - Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportBSE · exchange filing · pdf
Source filing Rekvina Laboratories Ltd - 526075 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Rekvina Laboratories Ltd - 526075 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Rekvina Laboratories Ltd - 526075 - Announcement under Regulation 30 (LODR)-Open Offer - UpdatesBSE · exchange filing · pdf
Source filing Rekvina Laboratories Ltd - 526075 - Draft Letter of OfferBSE · exchange filing · pdf
Source filing Rekvina Laboratories Ltd - 526075 - Detailed Public StatementBSE · exchange filing · pdf
Source filing Rekvina Laboratories Ltd - 526075 - Announcement under Regulation 30 (LODR)-Open Offer - UpdatesBSE · exchange filing · pdf
Source filing Rekvina Laboratories Ltd - 526075 - Closure of Trading WindowBSE · financial results · pdf
Source filing Rekvina Laboratories Ltd - 526075 - Shareholders Meeting -EGM 10.04.2026BSE · exchange filing · pdf
Source filing Rekvina Laboratories Ltd - 526075 - Announcement under Regulation 30 (LODR)-Public Announcement-Open OfferBSE · exchange filing · pdf
Source filing Rekvina Laboratories Ltd - 526075 - Open OfferBSE · exchange filing · pdf
Source filing Rekvina Laboratories Ltd - 526075 - Announcement under Regulation 30 (LODR)-Preferential IssueBSE · exchange filing · pdf
Source filing Rekvina Laboratories Ltd - 526075 - Board Meeting Outcome for Outcome Of Board MeetingBSE · exchange filing · pdf
Source filing Rekvina Laboratories Ltd - 526075 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationBSE · exchange filing · pdf
Source filing Rekvina Laboratories Ltd - 526075 - Board Meeting Intimation for PREFERENTIAL ISSUEBSE · exchange filing · pdf
Source filing Rekvina Laboratories Ltd - 526075 - Financial Results For The Quarter And Nine Months Ended On 31St December, 2025.
BSE · financial results · pdf
Source filing Rekvina Laboratories Ltd - 526075 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 06Th February, 2026BSE · exchange filing · pdf
Source filing Rekvina Laboratories Ltd - 526075 - Announcement under Regulation 30 (LODR)-Change in DirectorateBSE · exchange filing · pdf
Source filing Rekvina Laboratories Ltd - 526075 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 6Th February, 2026BSE · exchange filing · pdf
Source filing Rekvina Laboratories Ltd - 526075 - Announcement under Regulation 30 (LODR)-Change in DirectorateBSE · exchange filing · pdf
Source filing Rekvina Laboratories Ltd - 526075 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Rekvina Laboratories Ltd - 526075 - Announcement under Regulation 30 (LODR)-Change in DirectorateBSE · exchange filing · pdf
Source filing Rekvina Laboratories Ltd - 526075 - Closure of Trading WindowBSE · financial results · pdf
Source filing Rekvina Laboratories Ltd - 526075 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 14Th November, 2025BSE · exchange filing · pdf
Source filing Rekvina Laboratories Ltd - 526075 - Standalone Financial Result For The Period Ended On 30 September 2025BSE · financial results · pdf
Source filing Rekvina Laboratories Ltd - 526075 - Non-Applicability Of Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) (Amendment) Regulations, 2018, For The Half Year Ended On 30.09.2025.BSE · exchange filing · pdf
Source filing Rekvina Laboratories Ltd - 526075 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 14Th November, 2025.BSE · exchange filing · pdf
Source filing